Biodesix Inc.

NASDAQ: BDSX · Real-Time Price · USD
0.29
-0.01 (-4.26%)
At close: Jun 09, 2025, 3:59 PM

Biodesix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
71.32M 49.09M 38.21M 54.51M
Cost of Revenue
15.57M 13.01M 14.15M 30.52M
Gross Profit
55.75M 36.08M 24.06M 23.99M
Operating Income
-34.5M -41.34M -50.51M -39.32M
Interest Income
n/a n/a 8.07M 4.51M
Pretax Income
-42.93M -52.15M -65.45M -43.16M
Net Income
-42.93M -52.15M -80.39M -44.48M
Selling & General & Admin
80.45M 67.39M 61.46M 50.52M
Research & Development
9.56M 9.99M 13.1M 12.79M
Other Expenses
238K 44K 109K -9K
Operating Expenses
90.25M 77.42M 74.56M 63.31M
Interest Expense
8.26M 9.54M 8.07M 4.51M
Selling & Marketing Expenses
n/a n/a 61.46M 50.52M
Cost & Expenses
105.82M 90.43M 88.72M 93.82M
Income Tax Expense
n/a n/a 14.94M 1.32M
Shares Outstanding (Basic)
129.67M 82.11M 42.1M 27.36M
Shares Outstanding (Diluted)
129.67M 82.11M 42.1M 27.36M
EPS (Basic)
-0.33 -0.64 -1.91 -1.63
EPS (Diluted)
-0.33 -0.64 -1.91 -1.63
EBITDA
-29.22M -37.1M -53.78M -35.47M
EBIT
-34.67M -42.61M -57.38M -38.65M
Depreciation & Amortization
5.46M 5.51M 3.6M 3.18M